OUTLOOK THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable
OUTLOOK THERAPEUTICS, INC. (OTLK) reported Increase (Decrease) in Accounts Payable of -$3.63 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-18
- OUTLOOK THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$6.46M, a 416.48% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $5.71M.
- OUTLOOK THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$2.87M, a 168.03% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $30.25K, a 98.80% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2025 was $1.67M, a 19.50% increase from fiscal 2024.
- OUTLOOK THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2024 was $1.39M, a 54.78% decline from fiscal 2023.
- OUTLOOK THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2023 was $3.08M, a 138.05% increase from fiscal 2022.
- OUTLOOK THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2022 was $1.30M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-18 | -$754.67K derived: sum of 2 quarters · filed 2026-08-18 | -$3.63M 10-Q · filed 2026-08-18 | -$3.60M derived: sum of 4 quarters · filed 2026-08-18 | |||
| 2026-03-31 | $5.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | $2.83M 10-Q · filed 2026-05-15 | $2.86M derived: sum of 3 quarters · filed 2026-05-15 | $4.90M derived: sum of 4 quarters · filed 2026-08-18 | |||
| 2025-12-31 | -$2.87M 10-Q · filed 2026-02-17 | -$2.84M derived: sum of 2 quarters · filed 2026-02-17 | -$801.99K derived: sum of 3 quarters · filed 2026-08-18 | -$5.43M derived: sum of 4 quarters · filed 2026-08-18 | |||
| 2025-09-30 | $30.25K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-19 | $2.07M derived: sum of 2 quarters · filed 2026-08-18 | -$2.56M derived: sum of 3 quarters · filed 2026-08-18 | $1.67M 10-K · filed 2025-12-19 | |||
| 2025-06-30 | $2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-18 | -$2.59M derived: sum of 2 quarters · filed 2026-08-18 | $1.64M 10-Q · filed 2026-08-18 | $4.17M derived: sum of 4 quarters · filed 2026-08-18 | |||
| 2025-03-31 | -$4.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | -$405.70K 10-Q · filed 2026-05-15 | $2.13M derived: sum of 3 quarters · filed 2026-05-15 | $3.82M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $4.22M 10-Q · filed 2026-02-17 | $6.76M derived: sum of 2 quarters · filed 2026-02-17 | $8.45M derived: sum of 3 quarters · filed 2026-02-17 | $8.71M derived: sum of 4 quarters · filed 2026-02-17 | |||
| 2024-09-30 | $2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-19 | $4.22M derived: sum of 2 quarters · filed 2025-12-19 | $4.49M derived: sum of 3 quarters · filed 2025-12-19 | $1.39M 10-K · filed 2025-12-19 | |||
| 2024-06-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-14 | $1.96M derived: sum of 2 quarters · filed 2025-08-14 | -$1.14M 10-Q · filed 2025-08-14 | $621.86K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $267.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-15 | -$2.83M 10-Q · filed 2025-05-15 | -$1.07M derived: sum of 3 quarters · filed 2025-05-15 | $127.58K derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$3.09M 10-Q · filed 2025-02-14 | -$1.34M derived: sum of 2 quarters · filed 2025-02-14 | -$139.42K derived: sum of 3 quarters · filed 2025-02-14 | -$689.55K derived: sum of 4 quarters · filed 2025-02-14 | |||
| 2023-09-30 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-27 | $2.95M derived: sum of 2 quarters · filed 2024-12-27 | $2.40M derived: sum of 3 quarters · filed 2024-12-27 | $3.08M 10-K · filed 2024-12-27 | |||
| 2023-06-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-14 | $645.79K derived: sum of 2 quarters · filed 2024-08-14 | $1.32M 10-Q · filed 2024-08-14 | $2.33M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$550.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-15 | $128.26K 10-Q · filed 2024-05-15 | $1.14M derived: sum of 3 quarters · filed 2024-05-15 | -$540.24K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $678.39K 10-Q · filed 2024-02-14 | $1.69M derived: sum of 2 quarters · filed 2024-02-14 | $9.89K derived: sum of 3 quarters · filed 2024-02-14 | $1.80M derived: sum of 4 quarters · filed 2024-02-14 | |||
| 2022-09-30 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-22 | -$668.50K derived: sum of 2 quarters · filed 2023-12-22 | $1.13M derived: sum of 3 quarters · filed 2023-12-22 | $1.30M 10-K · filed 2023-12-22 | |||
| 2022-06-30 | -$1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | $115.35K derived: sum of 2 quarters · filed 2023-08-14 | $284.52K 10-Q · filed 2023-08-14 | -$107.98K derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-15 | $1.96M 10-Q · filed 2023-05-15 | $1.57M derived: sum of 3 quarters · filed 2023-05-15 | -$1.92M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $169.17K 10-Q · filed 2023-02-14 | -$223.33K derived: sum of 2 quarters · filed 2023-02-14 | -$3.71M derived: sum of 3 quarters · filed 2023-02-14 | -$968.65K derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2021-09-30 | -$392.50K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-29 | -$3.88M derived: sum of 2 quarters · filed 2022-12-29 | -$1.14M derived: sum of 3 quarters · filed 2022-12-29 | -$198.47K 10-K · filed 2022-12-29 | |||
| 2021-06-30 | -$3.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-10 | -$745.32K derived: sum of 2 quarters · filed 2022-08-10 | $194.03K 10-Q · filed 2022-08-10 | -$2.20M derived: sum of 4 quarters · filed 2022-08-10 | |||
| 2021-03-31 | $2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | $3.69M 10-Q · filed 2022-05-13 | $1.30M derived: sum of 3 quarters · filed 2022-05-13 | $1.17M derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $939.35K 10-Q · filed 2022-02-14 | -$1.45M derived: sum of 2 quarters · filed 2022-02-14 | -$1.58M derived: sum of 3 quarters · filed 2022-02-14 | -$840.59K derived: sum of 4 quarters · filed 2022-02-14 | |||
| 2020-09-30 | -$2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-23 | -$2.52M derived: sum of 2 quarters · filed 2021-12-23 | -$1.78M derived: sum of 3 quarters · filed 2021-12-23 | -$1.49M 10-K · filed 2021-12-23 | |||
| 2020-06-30 | -$128.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | $609.85K derived: sum of 2 quarters · filed 2021-08-13 | $900.03K 10-Q · filed 2021-08-13 | $1.50M derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $738.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-14 | $1.03M 10-Q · filed 2021-05-14 | $1.63M derived: sum of 3 quarters · filed 2021-05-14 | -$536.07K derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2019-12-31 | $290.18K 10-Q · filed 2021-02-16 | $894.50K derived: sum of 2 quarters · filed 2021-02-16 | -$1.27M derived: sum of 3 quarters · filed 2021-02-16 | -$780.52K derived: sum of 4 quarters · filed 2021-02-16 | |||
| 2019-09-30 | $604.32K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-23 | -$1.56M derived: sum of 2 quarters · filed 2020-12-23 | -$1.07M derived: sum of 3 quarters · filed 2020-12-23 | -$1.33M 10-K · filed 2020-12-23 | |||
| 2019-06-30 | -$2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-14 | -$1.68M derived: sum of 2 quarters · filed 2020-08-14 | -$1.94M 10-Q · filed 2020-08-14 | -$1.93M 10-Q · filed 2019-08-14 | -$648.02K derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | $494.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-15 | $233.16K 10-Q · filed 2020-05-15 | $233.57K 10-Q · filed 2019-05-15 | $1.52M derived: sum of 3 quarters · filed 2020-05-15 | $428.54K derived: sum of 4 quarters · filed 2020-05-15 | ||
| 2018-12-31 | -$260.94K 10-Q · filed 2020-02-14 | -$260.45K 10-Q · filed 2019-02-14 | $1.03M derived: sum of 2 quarters · filed 2020-02-14 | -$65.57K derived: sum of 3 quarters · filed 2020-02-14 | -$25.22K derived: sum of 4 quarters · filed 2020-02-14 | ||
| 2018-09-30 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-19 | $195.38K derived: sum of 2 quarters · filed 2019-12-19 | $235.72K derived: sum of 3 quarters · filed 2019-12-19 | -$6.71M 10-K · filed 2019-12-19 | |||
| 2018-06-30 | -$1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | -$1.05M derived: sum of 2 quarters · filed 2019-08-14 | -$8.00M 10-Q · filed 2019-08-14 | -$8.94M derived: sum of 4 quarters · filed 2019-08-14 | |||
| 2018-03-31 | $40.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-15 | -$6.91M 10-Q · filed 2019-05-15 | -$7.84M derived: sum of 3 quarters · filed 2019-05-15 | -$8.16M derived: sum of 4 quarters · filed 2019-05-15 | |||
| 2017-12-31 | -$6.95M 10-Q · filed 2019-02-14 | -$7.88M derived: sum of 2 quarters · filed 2019-02-14 | -$8.20M derived: sum of 3 quarters · filed 2019-02-14 | -$7.12M derived: sum of 4 quarters · filed 2019-02-14 | |||
| 2017-09-30 | -$934.43K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-18 | -$1.25M derived: sum of 2 quarters · filed 2018-12-18 | -$171.53K derived: sum of 3 quarters · filed 2018-12-18 | $5.73M 10-K · filed 2018-12-18 | |||
| 2017-06-30 | -$311.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | $762.91K derived: sum of 2 quarters · filed 2018-08-14 | $6.66M 10-Q · filed 2018-08-14 | $7.04M derived: sum of 4 quarters · filed 2018-08-14 | |||
| 2017-03-31 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-15 | $6.97M 10-Q · filed 2018-05-15 | $7.36M derived: sum of 3 quarters · filed 2018-05-15 | -$231.72K derived: sum of 4 quarters · filed 2018-05-15 | |||
| 2016-12-31 | $5.90M 10-Q · filed 2018-02-14 | $6.28M derived: sum of 2 quarters · filed 2018-02-14 | -$1.31M derived: sum of 3 quarters · filed 2018-02-14 | $806.23K derived: sum of 4 quarters · filed 2018-02-14 | |||
| 2016-09-30 | $382.52K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-29 | -$7.21M derived: sum of 2 quarters · filed 2017-12-29 | -$5.09M derived: sum of 3 quarters · filed 2017-12-29 | -$5.33M 10-K · filed 2017-12-29 | |||
| 2016-06-30 | -$7.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-14 | -$5.47M derived: sum of 2 quarters · filed 2017-08-14 | -$5.71M 10-Q · filed 2017-08-14 | -$1.61M derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2016-03-31 | $2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-15 | $1.88M 10-Q · filed 2017-05-15 | $5.98M derived: sum of 3 quarters · filed 2017-05-15 | $5.12M derived: sum of 4 quarters · filed 2017-05-15 | |||
| 2015-12-31 | -$233.94K 10-Q · filed 2017-02-14 | $3.87M derived: sum of 2 quarters · filed 2017-02-14 | $3.00M derived: sum of 3 quarters · filed 2017-02-14 | ||||
| 2015-09-30 | $4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-29 | $3.24M derived: sum of 2 quarters · filed 2016-12-29 | $6.58M 10-K · filed 2016-12-29 | ||||
| 2015-06-30 | -$865.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-15 | $2.48M 10-Q · filed 2016-08-15 | |||||
| 2015-03-31 | $3.34M 10-Q · filed 2016-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |